CARDIATEAM Overview
- Headquarters
- Paris, Fr
- Website
- cardiateam.eu
- Industry
- Research
- Employees
- 31
- Founded
- 2019
Keywords
About CARDIATEAM
The aim of CARDIATEAM is to determine whether T2DM represents a central mechanism contributing to the pathogenesis and progression of a specific cardiomyopathy, called “diabetic cardiomyopathy” (DCM), assessing whether DCM is unique and distinct from the other forms of heart failure. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 821508.
Compare Similar Companies to CARDIATEAM
Fogarty International Center at NIH
Research Services
iPAT - Institute for Particle Technology (Institut für Partikeltechnik)
Research Services
Imricor
Medical Equipment Manufacturing
Friends of the Global Fight Against AIDS, Tuberculosis and Malaria
International Affairs
Terrain Biosciences
Biotechnology Research
NEPHRIX Biosolutions
Biotechnology Research
Medical Device Developments
Book And Periodical Publishing
European Virus Bioinformatics Center
Higher Education
Alpha:Soft
Computer And Network Security
European Nucleotide Archive
Research Services